Patent details
EP2023950 Title: Urodilatin cancer treatment
Basic Information
- Publication number:
- EP2023950
- PCT Application Number:
- PCT/US/2007/011013
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP077768331
- PCT Publication Number:
- WO/2007/130672
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Urodilatin cancer treatment
- French Title of Invention:
- Traitement du cancer par l'urodilatine
- German Title of Invention:
- Krebsbehandlung mit Urodilatin
- SPC Number:
Dates
- Filing date:
- 07/05/2007
- Grant date:
- 11/07/2012
- EP Publication Date:
- 11/07/2012
- PCT Publication Date:
- 15/11/2007
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 18/02/2009
- EP B1 Publication Date:
- 11/07/2012
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 07/05/2013
- Expiration date:
- 07/05/2027
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 07/05/2007
- Name:
- United States Department of Veterans Affairs
- Address:
- 810 Vermont Avenue N.W., Washington, DC 20420, United States (US)
- Name:
- University of South Florida
- Address:
- 3802 Spectrum Blvd., Suite 100, Tampa, FL 33612, United States (US)
Inventor
- Name:
- VESELY David, L.
- Address:
- United States (US)
Priority
- Priority Number:
- 746562 P
- Priority Date:
- 05/05/2006
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 38/22;
| Filing date | Document type | Number of pages |
|---|